Minli Xie

Title: Minli Xie: Innovator in Pharmaceutical Formulations

Introduction

Minli Xie is a notable inventor based in Belmont, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the efficacy and delivery of hormone-related medications.

Latest Patents

Minli Xie holds a patent for "Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists." This patent includes combination solid oral dosage forms containing 40 mg of a specific compound, along with hormone replacement medicaments. The patent also outlines processes for making and using these solid oral dosage forms. This innovation is crucial for improving patient compliance and therapeutic outcomes.

Career Highlights

Minli Xie is associated with Sumitomo Pharma Co., Ltd., where he continues to advance pharmaceutical research and development. His expertise in formulating complex medications has positioned him as a valuable asset in the industry.

Collaborations

Minli has collaborated with esteemed colleagues, including David E Alonzo and Kathleen D Ullmer, who contribute to the diverse expertise within their team.

Conclusion

Minli Xie's innovative work in pharmaceutical formulations exemplifies the importance of research and development in improving healthcare solutions. His contributions are paving the way for more effective treatments in the field of medicine.